Balyasny Asset Management
SYNH

Balyasny Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Balyasny Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,000
Closed -$1.59M – 1803
2020
Q3 		$1.59M Buy
+30,000
New +$1.79M 0.01% 897
2017
Q2 		– Sell
-112,500
Closed -$5.16M – 1831
2017
Q1 		$5.16M Buy
+112,500
New +$5.6M 0.02% 693

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balyasny Asset Management's SYNH Position: Q3 2023 in Review

Balyasny Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 1,620,879 shares — an estimated $68.3M sold.

Balyasny Asset Management first reported a position in SYNH in Q3 2015 and held it in 24 quarters. The position peaked at $73.1M in Q4 2017. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Balyasny Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 1,620,879 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $68.3M.
  • Balyasny Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2015 and held it in 24 quarters.
  • Balyasny Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $73.1M in Q4 2017.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.